Your session is about to expire
← Back to Search
Depo-Provera Injectable Product for Delayed Onset of Lactation
Study Summary
This trial will test whether giving DMPA to women immediately postpartum, while they are still in the hospital, will increase breastfeeding and long-term contraceptive use compared to no injection or placebo.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
Is this trial pioneering a new field of research?
"As of now, 10 ongoing research initiatives concerning Depo-Provera Injectable Product are taking place in 37 cities and 7 nations. The initial clinical trial for this drug was organized by Novartis Pharmaceuticals back in 2015 and it had a participant pool of 74 patients that successfully concluded Phase 2 testing. Since then, 315 such studies have been conducted."
How reliable is Depo-Provera Injectable Product in terms of safety?
"The safety rating for this particular product is a 3 due to the fact that it has reached Phase 4, indicating approval from governing bodies."
Is the recruitment process for this experiment still active?
"Affirmative. According to information hosted on clinicaltrials.gov, this medical trial is currently in search of participants. This study was initially posted on March 21st 2019 and has been updated as recently as May 11th 2021. 800 patients are needed at a single site for the duration of the experiment."
What have physicians prescribed Depo-Provera Injectable Product to treat?
"Depo-Provera Injectable Product is frequently employed to address vasomotor symptoms of menopause, but can also be useful for endometrial hyperplasia management and relief from other pain. It has additionally been used as a form of contraception."
What is the aggregate amount of people participating in this experiment?
"Affirmative. The data found on clinicaltrials.gov attests that this medical experiment, posted March 21st 2019 and revised May 11th 2021, is actively looking for participants. 800 patients need to be enrolled across a single site."
Share this study with friends
Copy Link
Messenger